TD Asset Management »

Kymera Therapeutics shares owned by TD Asset Management

Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by TD Asset Management from 13F filings

Historical chart of TD Asset Management investment in Kymera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kymera Therapeutics held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kymera Therapeutics by TD Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $8.8M 219k 40.20
2023-12-31 $4.7M 187k 25.46
2023-09-30 $2.6M 184k 13.90
2023-06-30 $2.3M 100k 22.99
2023-03-31 $2.8M 94k 29.63
2022-12-31 $2.0M 80k 24.96
2022-09-30 $1.7M 79k 22.07
2022-06-30 $1.5M 77k 19.69
2022-03-31 $3.5M 84k 42.32
2021-12-31 $5.6M 88k 63.49
2021-09-30 $4.0M 68k 58.74
2021-06-30 $3.9M 65k 60.19
2021-03-31 $1.0M 27k 38.87
2020-12-31 $1.4M 23k 62.00
2020-09-30 $717k 22k 32.30